Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2022 | 3 |
2023 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Systematic review of prognostic factors in carcinoma ex pleomorphic adenoma.
Oral Oncol. 2022 Oct;133:106052. doi: 10.1016/j.oraloncology.2022.106052. Epub 2022 Jul 31.
Oral Oncol. 2022.
PMID: 35921695
Review.
OBJECTIVES: Carcinoma ex Pleomorphic Adenoma (CXPA) is a rare primary salivary gland malignancy, typically arising from a pre-existing pleomorphic adenoma. ...MATERIALS AND METHODS: Systematic review of MEDLINE, Cochrane, Scopus, Web of Science, CINAHL …
OBJECTIVES: Carcinoma ex Pleomorphic Adenoma (CXPA) is a rare primary salivary gland malignancy, typically arisi …
Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S, Chia C, Hasan Z, Sundaresan P, Riffat F, Dwivedi RC.
Key S, et al.
Laryngoscope. 2024 Mar;134(3):1042-1053. doi: 10.1002/lary.30993. Epub 2023 Aug 23.
Laryngoscope. 2024.
PMID: 37610148
Review.
OBJECTIVE: Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor. ...REVIEW METHODS: Systematic review and meta-analysis from inception to October 31, 2022 for all English language studies pertaining to "carcinoma e …
OBJECTIVE: Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor. ...REVIEW METHODS: …
Item in Clipboard
Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis.
Yan F, Lao WP, Nguyen SA, Sharma AK, Day TA.
Yan F, et al.
Head Neck. 2022 Feb;44(2):505-517. doi: 10.1002/hed.26923. Epub 2021 Dec 4.
Head Neck. 2022.
PMID: 34862810
Review.
ONM rates were 64% for salivary ductal carcinoma (SDC), 51% for undifferentiated carcinoma, 34% for carcinoma ex-pleomorphic adenoma (CXPA), 32% for adenocarcinoma not otherwise specified (ANOS), 31% for lymphoepithelial carcinoma (LE), 20% for mucoepi …
ONM rates were 64% for salivary ductal carcinoma (SDC), 51% for undifferentiated carcinoma, 34% for carcinoma ex-pleomorphi …
Item in Clipboard
Evaluation of HER2/neu expression in different types of salivary gland tumors: a systematic review and meta-analysis.
Javaheripour A, Saatloo MV, Vahed N, Gavgani LF, Kouhsoltani M.
Javaheripour A, et al.
J Med Life. 2022 May;15(5):595-600. doi: 10.25122/jml-2021-0394.
J Med Life. 2022.
PMID: 35815077
Free PMC article.
Review.
The highest rate of HER2 overexpression is present in malignant subtypes of salivary gland tumors, more specifically in salivary ductal carcinoma, mucoepidermoid carcinomas, salivary duct carcinoma in situ, and carcinoma ex pleomorphic adenoma....
The highest rate of HER2 overexpression is present in malignant subtypes of salivary gland tumors, more specifically in salivary ductal carc …
Item in Clipboard
Extracapsular invasion: A potential prognostic marker for Carcinoma ex-pleomorphic adenoma of the salivary glands? A Systematic Review.
de Morais EF, Pinheiro JC, Sena DAC, Galvão HC, de Souza LB, de Almeida Freitas R.
de Morais EF, et al.
J Oral Pathol Med. 2019 Jul;48(6):433-440. doi: 10.1111/jop.12841. Epub 2019 Feb 28.
J Oral Pathol Med. 2019.
PMID: 30756461
Item in Clipboard
Cite
Cite